| EPA0042 | Identification and characterization of HIV-1-specific CD8+ T cells in highly HIV-1 exposed but uninfected MsM in Vietnam | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0043 | Favourable transcriptomic signature of HIV-specific CD8 T cells in response to single anti-PD1 dose in people with HIV on ART and cancer | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0044 | CX3CR1+ macrophages as guardians of the intestinal barrier: lessons learnt from non-human primates exposed to SIV or SARS CoV-2 | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0045 | Longitudinal humoral and celular immune responses to mRNA SARS-CoV-2 vaccination in adolescents living with HIV | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0046 | Immunogenicity of conjugate meningococcal ACWY-TT vaccine in adolescents living with HIV | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0047 | Cryo-EM analysis provide structural insights for broad HIV-1 neutralization by a heavy chain matured antibody from an Indian pediatric elite-neutralizer | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0048 | Feasibility of iNKT cells as an immunotherapeutic HIV cure intervention | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0049 | HIV vaccine candidate efficacy mediated by epigenetic changes in CD14+ cells and cAMP-dependent efferocytosis | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0050 | Post-treatment controllers exhibit distinct CD8+ T cell features before and after ART interruption | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0051 | Specific immunological response after administration of anti-meningococcal quadrivalent conjugate vaccine MENVEO® in a population of vertically HIV-infected children, adolescents and young adults | E-poster | Host immune responses, vaccines and immunotherapies |